The INSULIN Act of 2026 mandates that group and individual health insurance plans cap out-of-pocket costs for selected insulin products at $35 per 30-day supply, effective for plan years beginning on or after January 1, 2028. This cost limit applies to a variety of insulin types and delivery devices, with the cap set at the lesser of $35 or 25 percent of the negotiated price net of concessions. The bill also prohibits insurers from imposing deductibles or prior authorization requirements for these covered products unless clinically justified for safety reasons.
Additionally, the legislation directs the Department of Health and Human Services to fund a resource center and hotline to help uninsured individuals find affordable insulin assistance programs, while requiring the Government Accountability Office to study the demographics of uninsured insulin users. Finally, it creates an expedited review process for biosimilar insulin applications when the Secretary determines there is inadequate competition in the market.
The Cancer Research Trust Fund Act establishes a dedicated trust fund within the Treasury to support cancer research initiatives. The fund is financed by allocating ten percent of the gross duties collected on imported tobacco and tobacco substitute products each fiscal year. These funds are transferred to the Secretary of Health and Human Services, who coordinates with the Department of Defense to conduct critical research into early screening, prevention, treatments, and innovative therapies. The legislation specifically directs that this research prioritize rare cancers and those affecting pediatric populations.
The Health Care Fraud Prevention and Enforcement Act mandates increased funding for federal agencies, including the Department of Justice, the Department of Health and Human Services, and the Federal Bureau of Investigation, to combat health care fraud and abuse starting in fiscal year 2027. The bill expands the investigative authority of the HHS Office of Inspector General to cover programs established under the Affordable Care Act and includes the State Children's Health Insurance Program in Medicare-Medicaid data matching efforts. Additionally, it requires the Government Accountability Office to conduct a study on the program's performance and effectiveness, with results due to Congress within 16 months of enactment.
The Health Insurance Transparency for Patients Act requires health insurance companies and Medicare Advantage organizations to publicly report detailed data on how they handle coverage requests. Starting with plan years after the law is passed, these providers must annually submit and display online information about the number and percentage of claims denied versus approved, along with the specific reasons for denials. The report must also break down data by the review method used, such as automated systems or human reviewers, and include the time it took to reach a decision. Additionally, the bill mandates that these organizations list all services requiring prior authorization and publish this information in a simple, easy-to-understand format. The Department of Health and Human Services will also make this data available on its own website to ensure public access.
The No Surprise Bills for New Moms Act updates federal health laws to ensure newborns receive immediate coverage for medical services within 30 days of birth. This legislation directly affects parents enrolled in group health plans, individual insurance policies, or employer-sponsored plans by mandating that these providers cover their newborns without requiring prior enrollment. The bill also requires insurers to offer a special enrollment period lasting at least 60 days after the initial coverage window and to notify parents immediately if a newborn is not enrolled when medical claims are submitted. By amending the Public Health Service Act, the Employee Retirement Income Security Act, and the Internal Revenue Code, the law standardizes these protections across different types of health insurance coverage.
This resolution designates June 15, 2026, as World Elder Abuse Awareness Day and the month of June 2026 as Elder Abuse Awareness Month. It formally recognizes the efforts of various professionals, including judges, social workers, and law enforcement, who work to prevent and address abuse against older adults. The bill also encourages the public and government agencies to continue collaborating on awareness campaigns and to report cases of elder abuse, neglect, and financial exploitation.
The Patients First Act of 2026 modifies how Medicare reimburses physicians and primary care providers to improve access and stabilize payments. It establishes a new hybrid payment model for primary care services from 2027 to 2031, which pays a monthly fee per patient to eligible independent practices while covering specific services like care management and telehealth without cost-sharing for patients. The bill also updates the formula for calculating reimbursement rates to account for high inflation years and requires more frequent updates to the costs used in calculating payments. Additionally, the legislation reforms the performance-based payment system by adding care efficiency measures, creating a task force to recommend new quality metrics, and adjusting penalties for providers who fail to report on certain data.
The Cure Hepatitis C Act of 2026 establishes a federal program to eliminate hepatitis C by creating a subscription model that allows the government to purchase antiviral drugs directly from manufacturers and distribute them at no cost to specific patient groups. These groups include individuals in Medicaid or CHIP programs, those without health insurance, patients in correctional facilities, and those receiving care through the Indian Health Service. The bill also expands Medicare coverage by removing deductibles and copayments for hepatitis C treatments between 2028 and 2032. To support these efforts, the legislation authorizes funding for state grants to improve screening and treatment access, mandates the creation of a national strategy and performance dashboard, and requires coordination with various federal agencies and stakeholders.
The Specialized Infant Formula Protection Act aims to guarantee a steady supply of specialized formula for preterm babies by centralizing legal oversight. It grants federal courts the authority to hear lawsuits involving injuries from FDA-regulated preterm infant formula, regardless of whether the parties are from different states or involve foreign defendants. Additionally, the law allows defendants to move such cases from state courts to federal courts without needing permission from all other defendants. These changes are designed to prevent fragmented legal battles in various state courts that could disrupt the domestic supply of this critical medical product.
The Prices on the Wall Act of 2026 requires hospitals, ambulatory surgical centers, laboratories, and imaging providers across the United States to display specific pricing information on their walls starting in 2028. This law mandates that these facilities post discounted cash prices for a list of services designated by the Centers for Medicare & Medicaid Services, or if those prices are unavailable, the median amount charged to self-pay patients over the previous three years. The displayed prices must be located in areas specified by the Secretary of Health and Human Services to ensure patients can see costs before receiving care. By making these financial details publicly visible, the bill aims to increase price transparency for consumers seeking scheduled medical services.
